 | Up a level |
2018
Auner, Holger W., Iacobelli, Simona, Sbianchi, Giulia, Knol-Bout, Cora, Blaise, Didier, Russell, Nigel H., Apperley, Jane F., Pohlreich, David, Browne, Paul V., Kobbe, Guido, Isaksson, Cecilia, Lenhoff, Stig, Scheid, Christof, Touzeau, Cyrille 
ORCID: 0000-0003-0275-2575, Jantunen, Esa, Anagnostopoulos, Achilles ORCID: 0000-0003-4384-9031, Yakoub-Agha, Ibrahim ORCID: 0000-0003-4524-8782, Tanase, Alina, Schaap, Nicolaas ORCID: 0000-0001-7696-4752, Wiktor-Jedrzejczak, Wieslaw, Krejci, Marta, Schoenland, Stefan O., Morris, Curly, Garderet, Laurent and Kroeger, Nicolaus
(2018).
Melphalan 140 mg/m(2) or 200 mg/m(2) for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM) study. A report by the EBMT Chronic Malignancies Working Party.
Haematologica, 103 (3).
S. 514 - 522.
PAVIA:
FERRATA STORTI FOUNDATION.
ISSN 0390-6078
Sahebi, Firoozeh, Iacobelli, Simona, Sbianchi, Giulia, Koster, Linda, Blaise, Didier, Remenyi, Peter, Russell, Nigel H., Ljungman, Per, Kobbe, Guido, Apperley, Jane, Trneny, Marek, Krejci, Marta, Wiktor-Jedrzejczak, Wieslaw, Sanchez, James F., Schaap, Nicolaas ORCID: 0000-0001-7696-4752, Isaksson, Cecilia, Lenhoff, Stig, Browne, Paul ORCID: 0000-0001-5310-1487, Scheid, Christof, Wilson, Keith M. O., Yakoub-Agha, Ibrahim ORCID: 0000-0003-4524-8782, Muniz, Soledad Gonzalez, Schoenland, Stefan, Morris, Curly, Garderet, Laurent and Kroeger, Nicolaus
(2018).
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents.
Biol. Blood Marrow Transplant., 24 (5).
S. 930 - 937.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1523-6536
2011
Basak, Grzegorz W., Mikala, Gabor, Koristek, Zdenek ORCID: 0000-0002-0478-854X, Jaksic, Ozren, Basic-Kinda, Sandra, Cegledi, Andrea, Reti, Marienn, Masszi, Tamas ORCID: 0000-0003-2322-9863, Mayer, Jiri, Giebel, Sebastian ORCID: 0000-0002-4827-4401, Huebel, Kai, Labar, Boris and Wiktor-Jedrzejczak, Wieslaw
(2011).
Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it's not too late.
Leuk. Lymphoma, 52 (9).
S. 1711 - 1720.
LONDON:
INFORMA HEALTHCARE.
ISSN 1042-8194